Taken together, there is sufficient evidence to speculate that the AhR may lessen the susceptibility to COPD pathogenesis by attenuating CS-induced pulmonary inflammation, oxidative stress, lung structural cell loss and bacterial infections that can trigger exacerbations (Figure 2). The gene discussed is AHR; the disease is bacterial infectious disease.